Education
About Us
Working with TipRanks
Follow Us
Exicure Inc (XCUR)
NASDAQ:XCUR
XCUR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.44 - $36.00
Previous CloseN/A
Volume39.94K
Average Volume (3M)84.50K
Market Cap
$46.12M
Enterprise Value$37.09M
Total Cash (Recent Filing)$12.51M
Total Debt (Recent Filing)$5.93M
Price to Earnings (P/E)―
Beta1.75
Next Earnings
Nov 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.41
Shares Outstanding6,317,793
10 Day Avg. Volume131,791
30 Day Avg. Volume84,501
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)4.12
Price to Sales (P/S)55.86
P/FCF Ratio-9.60
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue74.19
Enterprise Value/Gross Profit386.41
Enterprise Value/Ebitda-4.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Exicure News
XCUR FAQ
What was Exicure Inc’s price range in the past 12 months?
Exicure Inc lowest stock price was $1.44 and its highest was $36.00 in the past 12 months.
What is Exicure Inc’s market cap?
Exicure Inc’s market cap is $46.12M.
When is Exicure Inc’s upcoming earnings report date?
Exicure Inc’s upcoming earnings report date is Nov 13, 2025 which is in 89 days.
How were Exicure Inc’s earnings last quarter?
Exicure Inc released its earnings results on Aug 08, 2025. The company reported -$0.415 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.415.
Is Exicure Inc overvalued?
According to Wall Street analysts Exicure Inc’s price is currently Overvalued.
Does Exicure Inc pay dividends?
Exicure Inc does not currently pay dividends.
What is Exicure Inc’s EPS estimate?
Exicure Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Exicure Inc have?
Exicure Inc has 6,317,793 shares outstanding.
What happened to Exicure Inc’s price movement after its last earnings report?
Exicure Inc reported an EPS of -$0.415 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.745%.
Which hedge fund is a major shareholder of Exicure Inc?
Currently, no hedge funds are holding shares in XCUR
Exicure Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 22.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 8.9%
Last 30 Days ▼ 8.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
190.53%
12-Months-Change
Fundamentals
Return on Equity
-150.50%
Trailing 12-Months
Asset Growth
75.32%
Trailing 12-Months
Company Description
Exicure Inc
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Technical Analysis
ESSA Pharma
―
I-MAB
―
Unicycive Therapeutics
―
Caribou Biosciences
―
Vigil Neuroscience Inc
―
Ownership Overview
66.21% Insiders
0.49% Mutual Funds
4.46% Other Institutional Investors
28.36% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---